SKCM |
skin cutaneous melanoma |
GEO |
gene expression omnibus |
MRS |
monocyte-related signature |
DSS |
disease specific survival |
PFS |
progression free survival |
HLA |
human leukocyte antigen |
ICIs |
immune checkpoint inhibitors |
TME |
tumor microenvironment |
TIME |
tumor immune microenvironment |
scRNA-seq |
single-cell RNA sequencing |
CPM |
counts per million |
TCGA |
the cancer genome atlas |
PCA |
principal component analysis |
t-SNE |
t-Distributed Stochastic Neighbor Embedding |
NMF |
non-negative matrix factorization |
RSF |
random survival forest |
Enet |
elastic network |
plsRcox |
partial least squares regression for Cox |
SuperPC |
supervised principal components |
GBM |
generalized boosted regression modeling |
survival-SVM |
survival support vector machine |
LOOCV |
leave-one-out cross-validation |
ROC |
receiver operator characteristic curve |
DCA |
decision curve analysis |
ssGSEA |
single sample gene set enrichment analysis |
MsigDB |
Molecular Signatures Database |
GSEA |
gene set enrichment analysis |
GO |
Gene Ontology |
TISCH |
tumor immune single-cell hub |
IFITM3 |
interferon induced transmembrane protein |
AJCC |
American Joint Committee on Cancer |
HMOX1 |
Heme Oxygenase 1 |
HCC |
hepatocellular carcinoma |